KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Change in Account Payables: 2018-2025

Historic Change in Account Payables for Astrana Health (ASTH) over the last 8 years, with Q1 2025 value amounting to -$3.4 million.

  • Astrana Health's Change in Account Payables fell 614107.14% to -$3.4 million in Q1 2025 from the same period last year, while for Mar 2025 it was -$3.0 million, marking a year-over-year decrease of 14953.51%. This contributed to the annual value of $487000.0 for FY2024, which is 24847.56% up from last year.
  • Astrana Health's Change in Account Payables amounted to -$3.4 million in Q1 2025, which was down 614107.14% from $2.2 million recorded in Q4 2024.
  • In the past 5 years, Astrana Health's Change in Account Payables registered a high of $2.2 million during Q2 2021, and its lowest value of -$4.2 million during Q1 2022.
  • In the last 5 years, Astrana Health's Change in Account Payables had a median value of -$235000.0 in 2022 and averaged -$282470.6.
  • Its Change in Account Payables has fluctuated over the past 5 years, first skyrocketed by 144236.11% in 2021, then crashed by 614107.14% in 2025.
  • Quarter analysis of 5 years shows Astrana Health's Change in Account Payables stood at $1.7 million in 2021, then fell by 8.67% to $1.6 million in 2022, then fell by 5.07% to $1.5 million in 2023, then skyrocketed by 47.5% to $2.2 million in 2024, then plummeted by 254.97% to -$3.4 million in 2025.
  • Its Change in Account Payables was -$3.4 million in Q1 2025, compared to $2.2 million in Q4 2024 and -$1.3 million in Q3 2024.